Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 30,418 | 24,723 | 26,956 | 26,787 | 30,548 |
| Cost of Goods | 6,836 | 7,311 | 7,001 | 8,282 | 8,152 |
| Gross Profit | 23,582 | 17,412 | 19,955 | 18,505 | 22,396 |
| Operating Expenses | 12,503 | 12,241 | 10,194 | 10,214 | 11,302 |
| Operating Income | 11,915 | 5,482 | 9,762 | 8,573 | 11,246 |
| Other Income | 533 | 498 | 551 | 522 | 290 |
| Pre-tax Income | 12,448 | 5,980 | 10,313 | 9,095 | 11,536 |
| Income Tax | 3,013 | 1,473 | 2,596 | 1,496 | 1,444 |
| Net Income Continuous | 9,435 | 4,507 | 7,717 | 7,599 | 10,092 |
| Net Income | $9,435 | $4,507 | $7,717 | $7,599 | $10,092 |
| EPS Basic Total Ops | 0.68 | 0.32 | 0.54 | 0.53 | 0.69 |
| EPS Basic Continuous Ops | 0.68 | 0.32 | 0.53 | 0.53 | 0.69 |
| EPS Diluted Total Ops | 0.67 | 0.31 | 0.52 | 0.53 | 0.68 |
| EPS Diluted Continuous Ops | 0.67 | 0.31 | 0.52 | 0.53 | 0.68 |
| EBITDA(a) | $12,987 | $6,877 | $10,868 | $10,086 | $12,693 |